Methotrexate PF Closed System Transfer Device Kit is designed to support the safe handling and preparation of hazardous medications within hospital, oncology, and specialty pharmacy settings. Containing 125 mg per 5 mL in 0.9% sodium chloride at a concentration of 25 mg per mL, this kit provides a standardized format aligned with USP <800> handling expectations. With a beyond-use date of 135 days, pharmacy leaders may gain added flexibility in inventory management, waste reduction strategies, and coordinated treatment scheduling.
Each kit includes a 5 mL syringe prefilled with methotrexate and pre-attached to an ICU Medical Spinning Spiros adaptor, a 5 mL waste syringe with adaptor, an ICU Medical DoubleClave Syringe Transfer Set, a hazardous waste bag, and an Information for Use pamphlet. The syringe is wrapped in an amber protective bag and labeled at both the bag and syringe level to promote product integrity and clear identification. For pharmacy operations, this integrated configuration can help reduce compounding variability, minimize hazardous drug manipulation, and support consistent staff training across shifts and departments.
From an operational and compliance perspective, incorporating a closed system transfer device at the point of dispensing reinforces environmental safety protocols while improving workflow efficiency. Pharmacy decision-makers evaluating hazardous drug programs should consider how bundled drug and CSTD solutions may reduce surface contamination risk, support audit readiness, and strengthen overall medication safety initiatives.
